Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd    600332   CNE000001733

GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD

(600332)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/15/2016 | 09:15am EDT

The company will report its earnings for FY 2015 on 03/18/2016. Generally, the company reports earnings worse than estimates. In recent months, the 5 analysts from Thomson Reuters consensus have revised their EPS estimates downward.

Annual earnings per share is expected at 0.94 CNY for 2015 (+ 2.2% from 2014). A summary of annual publications and estimates is available below.

Annual results2012201320142015 (e)2016 (e)
Sales
Million CNY
Released
Forecast
Spread
8 229
6 861
20%
17 608
18 145
-3,0%
18 800
20 197
-6,9%

20 265

21 899
Operating income (EBITDA)
Million CNY
Released
Forecast
Spread
419
588
-29%
1 306
1 208
8,0%
1 563
1 477
5,9%

1 500

1 661
Operating profit (EBIT)
Million CNY
Released
Forecast
Spread
309
297
4,2%
1 120
1 088
2,9%
1 363
1 348
1,1%

1 426

1 612
Pre-Tax Profit (EBT)
Million CNY
Released
Forecast
Spread

404


1 467
1 528
-4,0%

1 649

1 920
Net income
Million CNY
Released
Forecast
Spread


980
1 016
-3,5%
1 192
1 220
-2,3%

1 315

1 531
EPS
 CNY
Released
Forecast
Spread
0,49
0,43
13%
0,77
0,83
-7,5%
0,92
0,95
-3,1%

0,94

1,02
Announcement Date03/01/201303/18/201403/19/2015

© MarketScreener.com 2016
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GUANGZHOU BAIYUNSHAN PHRMC
05/06GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan Pharm receives RMB358.29m gov't s..
AQ
04/29GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan Pharma 1Q net up 55% to RMB1.41bn
AQ
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan interim net up 126% to RMB2.6b; n..
AQ
2018GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Ex-dividend day for final dividend
FA
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : annual earnings release
2017GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Annual Report
CO
2017GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for final dividend
FA
2016GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for extraordinary dividen..
FA
2016GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : annual earnings release
2015GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for final dividend
FA
More news
Financials (CNY)
Sales 2019 55 778 M
EBIT 2019 3 496 M
Net income 2019 3 362 M
Finance 2019 11 833 M
Yield 2019 1,35%
P/E ratio 2019 20,63
P/E ratio 2020 17,85
EV / Sales 2019 0,93x
EV / Sales 2020 0,81x
Capitalization 63 471 M
Chart GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD
Duration : Period :
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU BAIYUNSHAN PHRMC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 41,2  CNY
Spread / Average Target 2,2%
EPS Revisions
Managers
NameTitle
Hong Li General Manager & Director
Chu Yuan Li Chairman
Jia Xiong Xian Chairman-Supervisory Board
Hin Wing Wong Independent Non-Executive Director
Chang Hai Wu Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD12.70%14 687
JOHNSON & JOHNSON10.10%348 981
PFIZER0.05%233 072
ROCHE HOLDING LTD.13.50%227 848
NOVARTIS21.44%220 893
MERCK AND COMPANY11.91%206 641